Effect of size and dose on the biodistribution of graphene oxide in mice

Nanomedicine

Volumn 7, Issue 12, 2012, Pages 1801-1812

  Liu, Jia Hui ^a,b   Yang, Sheng Tao ^a,b   Wang, Haifang ^b   Chang, Yanli ^b   Cao, Aoneng ^b   Liu, Yuanfang ^a  

^a PEKING UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

biodistribution; dose; graphene oxide; isotope labeling; size effect

Indexed keywords

GRAPHENE OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG UPTAKE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; GRAPHITE; INJECTIONS; LIVER; LUNG; MALE; MICE; NANOSTRUCTURES; OXIDES; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 84871327005     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.60     Document Type: Article

References (50)

1. Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine (Lond.) 6, 317-324 (2011).
2. Wang Y, Li Z, Wang J, Li J, Lin Y. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 29, 205-212 (2011).
3. Yang K, Zhang S, Zhang GX, Sun XM, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10, 3318-3323 (2010).
4. Chang YL, Yang ST, Liu JH et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 200, 201-210 (2011).
5. Zhang XY, Yin JL, Peng C et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 49, 986-995 (2011).
6. Yang K, Wan J, Zhang S, Zhang Y, Lee ST, Liu Z. In vivo pharmacokinetics, long-term biodistribution and toxicology of PEGylated graphene in mice. ACS Nano 5, 516-522 (2010).
7. Feng LZ, Zhang SA, Liu ZA. Graphene based gene transfection. Nanoscale 3, 1252-1257 (2011).
8. Ryoo SR, Kim YK, Kim MH, Min DH. Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano 4, 6587-6598 (2010).
9. Lu CH, Zhu CL, Li J, Liu JJ, Chen X, Yang HH. Using graphene to protect DNA from cleavage during cellular delivery. Chem. Commun. 46, 3116-3118 (2010).
10. Yang XY, Wang YS, Huang X et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J. Mater. Chem. 21, 3448-3454 (2011).
11. Zhang R, Hummelgård M, Lv G, Olin H. Real time monitoring of the drug release of rhodamine B on graphene oxide. Carbon 49, 1126-1132 (2011).
12. Zhang LM, Xia JG, Zhao QH, Liu LW, Zhang ZJ. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6, 537-544 (2010).
13. Liu Z, Robinson JT, Sun XM, Dai HJ. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876-10877 (2008).
14. Sun X, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1, 203-212 (2008).
15. Wang Y, Li ZH, Hu DH, Lin CT, Li JH, Lin YH. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J. Am. Chem. Soc. 132, 9274-9276 (2010).
16. Chen H, Müller MB, Gilmore KJ, Wallace GG, Li D. Mechanically strong, electrically conductive, and biocompatible graphene paper. Adv. Mater. 20, 3557-3561 (2008).
17. He S, Song B, Li D et al. A graphene nanoprobe for rapid, sensitive and multicolor fluorescent DNA analysis. Adv. Func. Mater. 20, 453-459 (2010).
18. Lu CH, Yang HH, Zhu CL, Chen X, Chen GN. A graphene platform for sensing biomolecules. Angew. Chem. Int. Ed. 48, 4785-4787 (2009).
19. Li Z, Geng Y, Zhang X et al. Biodistribution of co-exposure to multi-walled carbon nanotubes and graphene oxide nanoplatelets radiotracers. J. Nanopart. Res. 13, 2939-2947 (2010).
20. Hirn S, Semmler-Behnke M, Schleh C et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm. 77, 407-416 (2011).
21. Almeida JPM, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond.) 6, 815-835 (2011).
22. Balogh L, Nigavekar SS, Nair BM et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomed. Nanotechnol. 3, 281-296 (2007).
23. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B. Biointerfaces 66, 274-280 (2008).
24. Lacerda L, Ali-Boucetta H, Herrero MA et al. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomedicine (Lond.) 3, 149-161 (2008).
25. Yang ST, Guo W, Lin, Y et al. Biodistribution of pristine single-walled carbon nanotubes in vivo. J. Phys. Chem. C. 111, 17761-17764 (2007).
26. Yang ST, Fernando KAS, Liu JH et al. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small 4, 940-944 (2008).
27. Geys J, Nemmar A, Verbeken E et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ. Health Perspect. 116, 1607-1613 (2008).
28. Hummers WS, Offeman RE. Preparation of graphitic oxide. J. Am. Chem. Soc. 80, 1339-1339 (1958).
29. Steven CD, Meinken MA, Quinlin PM, Stewart PH. The distribution of radioactive iodine in mice with and without tumor 15091a after injection of radioactive sodium iodide. Cancer Res. 10, 155-161 (1950).
30. Singh SK, Singh MK, Nayak MK, Kumari S, Gracio JJA, Dash D. Size distribution analysis and physical/fluorescence characterization of graphene oxide sheets by flow cytometry. Carbon 49, 684-692 (2011).
31. Singh SK, Singh MK, Nayak MK et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 5, 4987-4996 (2011).
32. Liu JH, Yang ST, Wang H, Liu Y. Advances in biodistribution study and tracing methodology of carbon nanotubes. J. Nanosci. Nanotechnol. 10, 8469-8481 (2010).
33. Yang ST, Wang X, Jia G et al. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 181, 182-189 (2008).
34. Yang ST, Wang X, Wang H et al. Carbon dots as nontoxic and high-performance fluorescence imaging agents. J. Phys. Chem. C. 113, 18110-18114 (2009).
35. Johns Hopkins University Applied Physics Laboratory. APL Technical Digest (Volume 16). Applied Physics Laboratory, John Hopkins University, Baltimore, MD USA, 1-29 (1995).
36. Bordow RA, Ries AL, Morris TA. Pulmonary diagnostic techniques. In: Manual of Clinical Problems in Pulmonary Medicine. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 20-28 (2005).
37. Semmler-Behnke M, Kreyling WG, Lipka J et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4, 2108-2111 (2008).
38. Zhang G, Yang Z, Lu W et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30, 1928-1936 (2009).
39. Wang J, Zhou G, Chen C et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 168, 176-185 (2007).
40. Decuzzi P, Godin B, Tanaka T et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141, 320-327 (2010).
41. He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 7, 271-280 (2011).
42. Schipper ML, Iyer G, Koh AL et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5, 126-134 (2009).
43. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657-3666 (2010).
44. Liu J, Zeng F, Allen C. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. Eur. J. Pharm. Biopharm. 65, 309-319 (2007).
45. Kaminskas LM, Boyd BJ, Porter CJH. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine (Lond.) 6, 1063-1084 (2011).
46. Zhang X, Yin J, Kang C et al. Biodistribution and toxicity of nanodiamonds in mice after intratracheal instillation. Toxicol. Lett. 198, 237-243 (2010).
47. Akiyama Y, Mori T, Katayama Y, Niidome T. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J. Control. Release 139, 81-84 (2009).
48. Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int. J. Pharm. 221, 143-152 (2001).
49. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428-437 (2009).
50. Norman ME, Williams P, Illum L. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials 13, 841-849 (1992).